Appropriate Regulation of Human Renin Gene Expression and Secretion in 45-kb Human Renin Transgenic Mice by Yan Yan, Lufei Hu, Rong Chen, Jean E. Sealey,

Slides:



Advertisements
Similar presentations
Volume 134, Issue 7, Pages (June 2008)
Advertisements

Volume 119, Issue 5, Pages (November 2000)
by Yong Du, Aqing Yao, Dengfu Guo, Tadashi Inagami, and Donna H. Wang
Antioxidant Treatment Prevents Renal Damage and Dysfunction and Reduces Arterial Pressure in Salt-Sensitive Hypertension by Niu Tian, Kristina D. Thrasher,
Figure 1 Body weight of control and BPA-treated mothers after delivery
by Hideto Sano, Kohei Hosokawa, Hiroyasu Kidoya, and Nobuyuki Takakura
Carotid Artery Mechanical Properties of Dahl Salt-Sensitive Rats
by Jiaur R. Gayen, Kuixing Zhang, Satish P
Assessment of Unstable Atherosclerosis in Mice
Aberrant Renal Vascular Morphology and Renin Expression in Mutant Mice Lacking Angiotensin-Converting Enzyme by Karl F. Hilgers, Vasantha Reddi, John H.
Neuregulins Regulate Cardiac Parasympathetic Activity
Myeloid Suppressor Cells Accumulate and Regulate Blood Pressure in HypertensionNovelty and Significance by Kandarp H. Shah, Peng Shi, Jorge F. Giani, Tea.
Glycine Normalizes Hepatic Triglyceride-Rich VLDL Secretion by Triggering the CNS in High-Fat Fed RatsNovelty and Significance by Jessica T.Y. Yue, Patricia.
Impaired Renal Vasodilation and Urinary cGMP Excretion in Dahl Salt-Sensitive Rats by Shlomoh Simchon, William Manger, Gabriele Blumberg, Jeffrey Brensilver,
Pulse Pressure and Resistance Artery Structure in the Elderly
Novel Cis Element for Tissue-Specific Transcription of Rat Platelet-Derived Growth Factor β-Receptor Gene by Yasunori Takata, Yutaka Kitami, Tomikazu Fukuoka,
Differential Effects of Angiotensin II Type-1 Receptor Antisense Oligonucleotides on Renal Function in Spontaneously Hypertensive Rats by Minoru Yoneda,
The Calcium Paradoxon of Renin Release
Activation of Transient Receptor Potential Vanilloid Type-1 Channel Prevents Adipogenesis and Obesity by Li Li Zhang, Dao Yan Liu, Li Qun Ma, Zhi Dan Luo,
by Koji Yamamoto, Vivian de Waard, Colleen Fearns, and David J
Volume 131, Issue 2, Pages (August 2006)
Volume 69, Issue 6, Pages (March 2006)
Volume 55, Issue 3, Pages (March 1999)
Cyclophosphamide induces type I interferon and augments the number of CD44hi T lymphocytes in mice: implications for strategies of chemoimmunotherapy of.
Volume 59, Issue 5, Pages (May 2001)
Volume 68, Issue 6, Pages (December 2005)
Truman J. Milling, MD, Scott Kaatz, DO, MSc 
Counterregulation of Interleukin-18 mRNA and Protein Expression During Cutaneous Wound Repair in Mice  Heiko Kämpfer, Heiko Mühl, Josef Pfeilschifter,
Boye L. Jensen, Bianca Mann, Ole Skøtt, Armin Kurtz 
Furosemide stimulates macula densa cyclooxygenase-2 expression in rats
Volume 77, Issue 12, Pages (June 2010)
Volume 134, Issue 7, Pages (June 2008)
Volume 119, Issue 5, Pages (November 2000)
Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats  Julie Chao, Jenny J. Zhang, Kuei-Fu Lin,
Volume 5, Issue 1, Pages (July 2009)
Volume 18, Issue 2, Pages (August 2013)
Chapter 28 Nutrition, Lifestyle, and Hypertension
Volume 134, Issue 3, Pages (March 2008)
Volume 58, Issue 2, Pages (August 2000)
Ciara Metcalfe, Noelyn M. Kljavin, Ryan Ybarra, Frederic J. de Sauvage 
Volume 62, Issue 3, Pages (September 2002)
Volume 84, Issue 5, Pages (November 2013)
Erratum American Journal of Kidney Diseases
Salt and Hypertension American Journal of Kidney Diseases
Connexin40 regulates renin production and blood pressure
Volume 15, Issue 6, Pages (June 2007)
Salt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension
Volume 74, Issue 2, Pages (July 2008)
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
Volume 125, Issue 1, Pages (July 2003)
Human Papillomavirus E7 Oncoprotein Transgenic Skin Develops an Enhanced Inflammatory Response to 2,4-Dinitrochlorobenzene by an Arginase-1-Dependent.
Volume 1, Issue 2, Pages (February 2005)
Wei-Zhong Ying, Paul W. Sanders  Kidney International 
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Volume 58, Issue 4, Pages (October 2000)
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
Volume 6, Issue 1, Pages (July 2002)
The Suppressor of Cytokine Signaling (SOCS)-3 Determines Keratinocyte Proliferative and Migratory Potential during Skin Repair  Andreas Linke, Itamar.
Maryam G. Rohani, Ryan S. McMahan, Maria V. Razumova, Angie L
Volume 68, Issue 2, Pages (August 2005)
Volume 78, Issue 8, Pages (October 2010)
Renal Fibrosis and Plasma Creatinine Levels at 18 Weeks Post TAC (A) Plasma creatinine levels. (B) Representative images (original magnification ×20) of.
Increased Expression of Wnt2 and SFRP4 in Tsk Mouse Skin: Role of Wnt Signaling in Altered Dermal Fibrillin Deposition and Systemic Sclerosis  Julie Bayle,
Hideyuki Murakami, Katsutoshi Yayama, Lee Chao, Julie Chao 
Volume 59, Issue 3, Pages (March 2001)
Adenovirus-mediated gene transfer to renal glomeruli in rodents
Volume 74, Issue 4, Pages (August 2008)
Volume 25, Issue 4, Pages (April 2017)
Volume 75, Issue 5, Pages (March 2009)
Fig. 2. SUS reduces Aβ plaques in an AD mouse model.
Presentation transcript:

Appropriate Regulation of Human Renin Gene Expression and Secretion in 45-kb Human Renin Transgenic Mice by Yan Yan, Lufei Hu, Rong Chen, Jean E. Sealey, John H. Laragh, and Daniel F. Catanzaro Hypertension Volume 32(2):205-214 August 1, 1998 Copyright © American Heart Association, Inc. All rights reserved.

A, Human and mouse PRC and ProRC in response to dietary salt: medium, 0.28% NaCl (MED; n=5); high, 8% NaCl (n=5); and low, 0.014% NaCl (n=4). *P<0.0001 and +P<0.005, compared with low salt (Scheffé’s test). A, Human and mouse PRC and ProRC in response to dietary salt: medium, 0.28% NaCl (MED; n=5); high, 8% NaCl (n=5); and low, 0.014% NaCl (n=4). *P<0.0001 and +P<0.005, compared with low salt (Scheffé’s test). B, Effects of captopril on human and mouse PRC and ProRC: control, 0.28% NaCl diet (n=5); captopril, 0.28% NaCl diet plus captopril 0.5 mg/mL in drinking water. *P<0.0001, +P<0.005, †P<0.05, compared with control (Scheffé’s test). Open bars indicate nontransgenic mice; hatched bars, transgenic mice. Yan Yan et al. Hypertension. 1998;32:205-214 Copyright © American Heart Association, Inc. All rights reserved.

RNase protection assay of renal RNA for animals fed salt-modified diets (A) and treated with captopril (B). RNase protection assay of renal RNA for animals fed salt-modified diets (A) and treated with captopril (B). The positions of hREN-, mRen-1C–, and 18S rRNA–specific protection products are indicated. Numbers at the bottom of the figure indicate the amount of human or mouse renin mRNA in each sample (arbitrary unit, normalized by the amount of 18S rRNA). Exposure time was 16 hours. Quantification of renal renin RNA levels in animals fed different salt diets (C) and in captopril-treated mice (D). Data were quantified from RNase protection assays shown in panels A and B after normalization from measurements of samples run in both assays. *P<0.0001 compared with control; †P<0.05 compared with low salt. Open bars indicate nontransgenic; hatched bars, transgenic. Yan Yan et al. Hypertension. 1998;32:205-214 Copyright © American Heart Association, Inc. All rights reserved.

Serial sections of kidneys from a transgenic mouse fed a normal salt diet (control) and a transgenic mouse treated with captopril for 16 days. Serial sections of kidneys from a transgenic mouse fed a normal salt diet (control) and a transgenic mouse treated with captopril for 16 days. Panels A, B, E, and F were from the control mouse; and panels C, D, G, and H were from the captopril-treated mouse. Panels A, C, E, and G stained for both mouse and human renin (BR1-5); and panels B, F, D, and H stained for human renin (R15). Upper panels (A–D) are from lower power magnification (×6), and lower panels (E–H) are central portions of the upper panels at higher magnification (×40). Yan Yan et al. Hypertension. 1998;32:205-214 Copyright © American Heart Association, Inc. All rights reserved.

β-Adrenergic control of human and mouse renin secretion. β-Adrenergic control of human and mouse renin secretion. S indicates saline; P, propranolol; I, isoproterenol; and P+I, propranolol followed by isoproterenol. *P<0.0001 compared with I. Open bars indicate nontransgenic; hatched bars, transgenic. Yan Yan et al. Hypertension. 1998;32:205-214 Copyright © American Heart Association, Inc. All rights reserved.

A, Continuous femoral blood pressure tracing in an anesthetized male mouse. A, Continuous femoral blood pressure tracing in an anesthetized male mouse. NxRP indicates nephrectomized rat plasma. Effect of intravenous infusion of AGT on plasma AGT (AOGN) (B), blood pressure (C), mouse PRC (D), and human PRC (E) in anesthetized male transgenic mice. AGT levels are shown as actual values. For other parameters, measurements taken 15 minutes after the initiation of the saline infusion were used as controls. Subsequent measurements were normalized to control levels and expressed as percentages. Nephrectomized rat plasma or human AGT were added to the infusion between 0 and 30 minutes (indicated by the solid bar). +P<0.001; †P<0.05. Yan Yan et al. Hypertension. 1998;32:205-214 Copyright © American Heart Association, Inc. All rights reserved.

Relationship of human PRC to mouse PRC for all experiments reported in the present study. Yan Yan et al. Hypertension. 1998;32:205-214 Copyright © American Heart Association, Inc. All rights reserved.

Relationship of ProRC, PRC, and TRC to renal renin mRNA levels for the data shown in Figures 1, 2, and 5. Relationship of ProRC, PRC, and TRC to renal renin mRNA levels for the data shown in Figures 1, 2, and 5. Human plasma renin levels are plotted against human renal mRNA, and mouse plasma renin levels are plotted against mouse renal renin mRNA. Yan Yan et al. Hypertension. 1998;32:205-214 Copyright © American Heart Association, Inc. All rights reserved.